Navigation Links
Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
Date:11/8/2012

SOUTH SAN FRANCISCO, Calif., Nov. 8, 2012 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the Jefferies 2012 Global Healthcare Conference in London on Thursday, November 15th at 1:40 p.m. GMT.

To access the live webcast of the presentation or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis with its partner AstraZeneca; R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 clinical trials; and R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders.

Contact: Ryan Maynard   
Phone: 650.624.1284   
Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Rigel Announces Third Quarter 2012 Financial Results
2. Rigel to Present at UBS Global Life Sciences Conference
3. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
4. Rigel Announces Second Quarter 2012 Financial Results
5. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
6. Rigel Announces First Quarter 2012 Financial Results
7. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
9. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
10. VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings
11. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced that the Company ... from its partner Asahi Kasei Pharma Corporation (Asahi ... successful submission of a regulatory application to the ... XIAFLEX ® (collagenase clostridium histolyticum) for the ...
(Date:7/31/2014)... 31 juli 2014 De Pfizer Clinical Research ... voor gezonde vrijwilligers van Japanse komaf voor medewerking aan ... gevestigde PCRU is één van twee onderzoekseenheden van ... levens te verbeteren door de ontdekking en ontwikkeling van ... op zoek naar mannen en vrouwen van Japanse komaf ...
(Date:7/30/2014)... Inc. (NASDAQ: HOLX ) today announced its ... 2014. Third Quarter Financial Highlights and Recent ... reflecting operational growth of 0.5% and a positive currency ... the prior year. , Revenues grew in three ... grew 3.5%. , GYN Surgical revenues grew 3.5%. ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17
(Date:7/31/2014)... 31, 2014 The shale gas development ... top of current U.S. natural gas production has raised ... and bust” cycle, similar to previous resource extraction experiences ... today by Washington & Jefferson College’s (W&J) Center for ... Institute (ELI) confirms that the gas boom in Pennsylvania ...
(Date:7/31/2014)... Computer Resources of America, Inc. (CRA), ... York City, has been awarded the contract to rewire ... of a large global bank. The bank is a ... Ramnarayan, Chief Executive Officer of CRA said, “Being awarded ... us to further develop what has already been a ...
(Date:7/31/2014)... The Brosix team takes great pride in giving back ... part in the TuxCon conference at International Fair Plovdiv. ... events, including speakers from Bulgaria, Turkey and Greece. Topics ... software for mobile, embedded and wearable devices. , Brosix ... conference, presenting a segment entitled “Mobile Applications that Communicate.” ...
(Date:7/31/2014)... July 31, 2014 Perhaps some people are ... are getting old from the first day when we were ... ups and downs during their whole life. Some people may ... (like China), it is not necessary for people to worry ... help; FODAY Auto, a famous China automobile manufacturer , ...
(Date:7/31/2014)... 31, 2014 Updox, the industry ... announces the release of a “Twelve Questions to Ask When ... that are evaluating Health Information Service Providers (HISPs) for Direct ... utilize MEDITECH and Epic electronic health records (EHRs) need to ... of care using the Direct protocol. , “Selecting ...
Breaking Medicine News(10 mins):Health News:Pennsylvania’s Shale Gas: Examining the Boom and Bust Cycle 2Health News:Pennsylvania’s Shale Gas: Examining the Boom and Bust Cycle 3Health News:Global Bank Awards CRA with Network Infrastructure Contract 2Health News:Brosix Takes Part in TuxCon Conference 2Health News:FodayAuto.com: Do Not Be Afraid of Getting Old 2Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 2Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 3Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 4
... Pharmacy Join Forces for Jude Andrew ... Adams Charitable Fund, ... announce that they have joined to offer Braun Pharmacy,customers free overnight ... filled for individual cycles to the,Jude Andrew Adams Charitable Fund, a ...
... Flagship Global Health,Inc. (OTC Bulletin Board: FGHH) today ... 2008 as the date for the Company,s annual stockholder,s,meeting. ... later date., About Flagship Global Health, Flagship ... level of healthcare quality for its members, whether,they are ...
... One of the nations oldest and most respected ... travel fellowships to underrepresented minority students and scientists to ... April 5-9. The American Physiological Society (APS), which administers ... the travel awards. , APS administers the program with ...
... MINNEAPOLIS, March 18 A landmark study ... Association documents how medication,therapy management (MTM) services, ... Care System(TM), produced both improved,clinical outcomes and ... Economic Outcomes of Medication Therapy Management Services:,The ...
... In an,unprecedented election, nursing home and home ... of United Healthcare,Workers-West, demonstrating their unwillingness to ... Union local branch., (Photo: http://www.newscom.com/cgi-bin/prnh/20080318/DC17028 ... disinformation campaign,aimed at suppressing voter turnout, 99 ...
... Smart Balance Inc.,(Nasdaq: SMBL ) announced today ... annual Citi Small/Midcap Conference in Las Vegas, NV, at,12:25 ... Hughes, Chairman and Chief Executive Officer and Alan Gever,Executive ... at the conference as well as through the webcast. ...
Cached Medicine News:Health News:Infertility Consultancy and Chicago Pharmacy Bring Hope to Infertile Couples 2Health News:52 minority scientists receive travel fellowships to Experimental Biology 2008 2Health News:52 minority scientists receive travel fellowships to Experimental Biology 2008 3Health News:MTM Study Reports Improved Quality and Economic Outcomes Using Medication Management Systems' Assurance Pharmaceutical Care System(TM) 2Health News:California Nursing Home, Homecare Workers Vote Overwhelmingly to Preempt Forced Transfer 2Health News:California Nursing Home, Homecare Workers Vote Overwhelmingly to Preempt Forced Transfer 3Health News:Smart Balance to Webcast Presentation at Citi Small/Midcap Conference 2
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
... This remarkable anti-reflux valve is ... housing which prevents the valve ... when in sitting or reclining ... self-cleaning and interference free ensuring ...
... AggRAM, for platelet aggregation and ristocetin ... with the power of Windows-based software ... to two AggRAM modules can be ... computer so you can configure your ...
The Multiple Perfusion set provides simultaneous perfusion of the aortic root and up to three or more vein grafts. The set features an inlet port with female luer and clamp attached to an adapter whi...
Medicine Products: